The proposed project, performed with the company Immune Biosolutions, aims to develop superior antibodies for biological targets of interest for the treatment of colorectal cancer. Specifically, these targets are a class of proteins expressed on cell surface, which are notoriously difficult for the development of antibodies. The method involves making molecules look like the biological target, in order to elicit antibody responses which are more specific to the targets. The proposed project will have a technological impact that will make biomedical research more reliable by providing better tools, as well as a translational impact by providing molecules to validate new targets for the treatment of colorectal cancer.
Pharmacy / Pharmacology
Find the perfect opportunity to put your academic skills and knowledge into practice!Find Projects
The strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.